High CMV-specific T cell response at day 0 in hematopoietic stem cell transplant (HCT) recipients was associated with CMV infection after HCT. Low CMV-specific T cell response at day 30 in HCT recipients was associated with CMV infection after HCT. Monitoring dynamic changes of CMV-specific immunity is useful for identifying HCT recipients at risk of CMV infection.